BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33836365)

  • 21. Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery.
    Herrera-Guzmán I; Gudayol-Ferré E; Herrera-Abarca JE; Herrera-Guzmán D; Montelongo-Pedraza P; Padrós Blázquez F; Peró-Cebollero M; Guàrdia-Olmos J
    J Affect Disord; 2010 Jun; 123(1-3):341-50. PubMed ID: 19896719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Four Machine Learning Techniques for Prediction of Intensive Care Unit Length of Stay in Heart Transplantation Patients.
    Wang K; Yan LZ; Li WZ; Jiang C; Wang NN; Zheng Q; Dong NG; Shi JW
    Front Cardiovasc Med; 2022; 9():863642. PubMed ID: 35800164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute trajectories of neural activation predict remission to pharmacotherapy in late-life depression.
    Karim HT; Wang M; Andreescu C; Tudorascu D; Butters MA; Karp JF; Reynolds CF; Aizenstein HJ
    Neuroimage Clin; 2018; 19():831-839. PubMed ID: 30013927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of low cardiac output syndrome in patients following cardiac surgery using machine learning.
    Hong L; Xu H; Ge C; Tao H; Shen X; Song X; Guan D; Zhang C
    Front Med (Lausanne); 2022; 9():973147. PubMed ID: 36091676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: A retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases.
    Peng S; Huang J; Liu X; Deng J; Sun C; Tang J; Chen H; Cao W; Wang W; Duan X; Luo X; Peng S
    Front Cardiovasc Med; 2022; 9():994359. PubMed ID: 36312291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying patients with major depressive disorder based on tryptophan hydroxylase-2 methylation using machine learning algorithms.
    Fan R; Hua T; Shen T; Jiao Z; Yue Q; Chen B; Xu Z
    Psychiatry Res; 2021 Dec; 306():114258. PubMed ID: 34749226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A wavelet-based technique to predict treatment outcome for Major Depressive Disorder.
    Mumtaz W; Xia L; Mohd Yasin MA; Azhar Ali SS; Malik AS
    PLoS One; 2017; 12(2):e0171409. PubMed ID: 28152063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting remission by 8 weeks: when should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor?
    Cooper-Kazaz R; Rigbi A; Lerer B
    Compr Psychiatry; 2011; 52(1):9-16. PubMed ID: 21220060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.
    Thase ME; Pritchett YL; Ossanna MJ; Swindle RW; Xu J; Detke MJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):672-6. PubMed ID: 18004135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of the development of acute kidney injury following cardiac surgery by machine learning.
    Tseng PY; Chen YT; Wang CH; Chiu KM; Peng YS; Hsu SP; Chen KL; Yang CY; Lee OK
    Crit Care; 2020 Jul; 24(1):478. PubMed ID: 32736589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union.
    Cooper JA; Tucker VL; Papakostas GI
    J Psychopharmacol; 2014 Feb; 28(2):118-24. PubMed ID: 24352716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.
    Athreya AP; Neavin D; Carrillo-Roa T; Skime M; Biernacka J; Frye MA; Rush AJ; Wang L; Binder EB; Iyer RK; Weinshilboum RM; Bobo WV
    Clin Pharmacol Ther; 2019 Oct; 106(4):855-865. PubMed ID: 31012492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Explainable machine learning for chronic lymphocytic leukemia treatment prediction using only inexpensive tests.
    Meiseles A; Paley D; Ziv M; Hadid Y; Rokach L; Tadmor T
    Comput Biol Med; 2022 Jun; 145():105490. PubMed ID: 35405402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting inadequate postoperative pain management in depressed patients: A machine learning approach.
    Parthipan A; Banerjee I; Humphreys K; Asch SM; Curtin C; Carroll I; Hernandez-Boussard T
    PLoS One; 2019; 14(2):e0210575. PubMed ID: 30726237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder.
    Varigonda AL; Jakubovski E; Taylor MJ; Freemantle N; Coughlin C; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2015 Jul; 54(7):557-64. PubMed ID: 26088660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
    Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
    J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alterations of brain functional connectivity networks in major depressive disorder detected by machine learning through multisite rs-fMRI data.
    Dai P; Xiong T; Zhou X; Ou Y; Li Y; Kui X; Chen Z; Zou B; Li W; Huang Z; The Rest-Meta-Mdd Consortium
    Behav Brain Res; 2022 Oct; 435():114058. PubMed ID: 35995263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive Changes in Selective Serotonin Reuptake Inhibitors-Treated Adolescents with Depression.
    Shehab AA; Brent D; Maalouf FT
    J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):713-720. PubMed ID: 26974181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings.
    Athreya AP; Brückl T; Binder EB; John Rush A; Biernacka J; Frye MA; Neavin D; Skime M; Monrad D; Iyer RK; Mayes T; Trivedi M; Carter RE; Wang L; Weinshilboum RM; Croarkin PE; Bobo WV
    Neuropsychopharmacology; 2021 Jun; 46(7):1272-1282. PubMed ID: 33452433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.